Funding · Company
Ansa Biotechnologies, Inc.
Emeryville, CABiotech & Pharma
Ansa Biotechnologies, Inc. of Emeryville, CA has disclosed $114M across 2 Form D offerings filed with the SEC between May 5, 2022 and Dec 10, 2025.
$114M
Total disclosed
2
Form D offerings
2018
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$46M
Form D · Dec 10, 2025 ↗
Q4 2025
· 1 amendment, first filed Oct 2, 2025
· target $57M
$68M
Form D · May 5, 2022 ↗
Q2 2022
· 1 amendment, first filed Apr 14, 2022
· target $77M
Filing details
HeadquartersEmeryville, CAIndustryBiotech & Pharma (Biotechnology)Incorporated2018SEC CIK0001816722Offerings on file2
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →